Oct 21 (Reuters) - Biogaia AB BIOGb.ST :
* BIOGAIA AB: INTERIM REPORT THIRD QUARTER JANUARY -
SEPTEMBER
2022
* Q3 NET SALES AMOUNTED TO SEK 257.7 MILLION (173.8)
* Q3 OPERATING PROFIT INCREASED BY 40% TO SEK 93.7 MILLION
(67.2)
* Q3 PROFIT AFTER TAX AMOUNTED TO SEK 79.5 MILLION (52.8)
* DEMAND WILL PROBABLY REMAIN STRONG FOR OUR PROTECTIS DROPS
FOR
INFANTS WITH COLIC REGARDLESS OF ECONOMIC SITUATION, WHILE OUR
PRODUCTS IN ADULT HEALTH SEGMENT FOR WELL-BEING MAY BE AFFECTED
BY TOUGHER ECONOMIC TIMES
* IN OUR AMERICAS MARKET AREA, WE CAN SEE THAT INFLATION IS
BEGINNING TO IMPACT PURCHASING POWER IN USA
Source text for Eikon: ID:nWkr1QYP2n
Further company coverage: BIOGb.ST
(Gdansk Newsroom)
((gdansk.newsroom@thomsonreuters.com; +48 58 7696600;))